More Business Wire
View Older Stories View Newer Stories-
Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
-
ON24 Named a Leader in 2023-2024 IDC MarketScape for Virtual Events Applications
-
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2023, Provides Financial Outlook for 2024
-
Skyhigh Security Provides Oracle Customers with Intelligent Web Security, Consolidated Management and Simplified Regulatory Compliance
-
FICO Supercharges Business Outcomes with Innovations in Simulation Technology on FICO Platform
-
bioAffinity Technologies In the News
-
Blue Ridge and Plative Team Up for Supply Chain Technology Enhancements
-
IHOP® Kicks off 2024 With a Rooty Tooty Fresh ‘N Fruity® Extravaganza
-
BigCommerce and Marketplacer Announce Strategic Partnership to Help Retailers Accelerate Growth
-
Nexstar Media Enters Into Time Brokerage Agreement With KAZT-TV in Phoenix, Arizona
-
DermTech Announces Positive Topline Results From Trust 2 Study Evaluating the DermTech Melanoma Test (DMT)
-
Leixir Dental Laboratory Group Appoints John Krier as Chief Executive Officer
-
Vitacost Celebrates 30 Years of Wellness With Year-Long 30% Off Promotion
-
Debiopharm Extends SunRock Biopharma Partnership for Antibody Drug Conjugates Targeting HER3 in EGFR Mutated Cancers
-
USound Uncovers the Future of MEMS Technology at CES 2024
-
Stellar Cyber Wins Two 2023 ASTOR Awards
-
Applebee’s Teams Up with Dos Hombres to Debut Three NEW Mezcal Margaritas
-
Accenture Invests in QuantHealth to Accelerate Use of AI-powered Clinical Trial Simulations to Drive Cost-Effective Drug Development
-
Altius Provides 2023 Year-End Project Generation Update
-
MindMed Announces Business Update and Anticipated Milestones for 2024
-
Kobo Resources to Attend the 2024 Vancouver Resource Investment Conference
-
Medable’s New Intelligent Automation Capabilities Cut Clinical Trial Technology Deployment Timelines By 50%
-
Masonite Reiterates the Compelling Value of its Agreement to Acquire PGT Innovations
-
Cybin Announces Positive Topline Data from Phase 1 Studies of Proprietary Deuterated DMT Molecules CYB004 and SPL028
-
Western Exploration Provides Update on Drilling Activities at Gravel Creek
-
PGT Innovations Board of Directors Determines that Miter’s Unsolicited Proposal Would Reasonably Be Expected to Lead to a Superior Proposal
-
Merck to Acquire Harpoon Therapeutics, Further Diversifying Oncology Pipeline
-
Aramark Launches New Telehealth Program to Digitally Connect Hospital Inpatients with Clinical Nutrition Services
-
Eikon Therapeutics to Provide Corporate Updates at the 42nd Annual J.P. Morgan Healthcare Conference
-
Rockwell Medical Amends Loan and Security Agreement with Innovatus Life Sciences Lending Fund
-
Schrödinger Provides Update on Progress Across the Business and Outlines 2024 Development and Operational Goals
-
Organon affirms 2023 revenue and Adjusted EBITDA guidance and provides 2024 outlook
-
NerdWallet Announces Winners of its 2024 Best-Of Awards
-
Johnson & Johnson to Acquire Ambrx, Advancing Next Generation Antibody Drug Conjugates to Transform the Treatment of Cancer
-
Camping World Set to Acquire Three Locations in Texas and Oklahoma
-
Capstan Therapeutics Appoints Ramin Farzaneh-Far, M.D., as Chief Medical Officer and Announces Key Business Leadership Promotion
-
Gibraltar to Present at CJS Securities 24th Annual "New Ideas for the New Year" Conference
-
Bread FinancialTM Announces Private Offering of Additional 9.750% Senior Notes Due 2029
-
Citi Trends Announces 2023 Holiday Sales Results for Quarter-to-date Through January 6, 2024
-
BXP to Release Fourth Quarter & Full Year 2023 Financial Results on January 30, 2024
-
KBRA Assigns Preliminary Ratings to Together Asset Backed Securitisation 2024-2ND1 PLC
-
Mobileye Reveals New Wins for Key Tech Platforms with Large Global Automaker
-
Immunis Chairman Dr. Hans Keirstead to Speak at the Longevity Investors Lunch in Davos
-
Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON
-
Nu Skin Enterprises to Discuss Company Strategy and Opportunities at ICR Conference
-
Immunome Exclusively Licenses Zentalis ROR1 Antibody-Drug Conjugate and Proprietary Technology Platform
-
Calidi Biotherapeutics Announces the Appointment of Three New Members to its Scientific and Medical Advisory Board
-
Axonics Announces Definitive Agreement to be Acquired by Boston Scientific
-
Clarest Health Acquires Remedi SeniorCare in Strategic Move to Redefine Personalized Medication Management for Aging Population
-
Aeva Introduces Atlas – The First Automotive-Grade 4D LiDAR Sensor for Mass Production Automotive Applications
